Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEngage Xr Regulatory News (EXR)

Share Price Information for Engage Xr (EXR)

Share Price is delayed by 15 minutes
Get Live Data
0.215    0.00 (0.00%)
Bid:
0.18
Ask:
0.25
Spread: 0.07 (38.889%)
Market Cap: £1.13m
EXR Live PriceLast checked at - London Stock Exchange

Intraday Engage Xr Share Chart

EPT Disclosure

24 Apr 2008 11:20

Bear Stearns Intl. Trading Ltd24 April 2008 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(b) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader Bear, Stearns International Trading LimitedCompany dealt in Expro International Group PLCClass of relevant security to which thedealings being disclosed relate (Note 1) 10p OrdinaryDate of dealing 23 April 2008 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class ofrelevant security dealt in (Note 2) Long Short Number Number (%) (%) (1) Relevant securities 62,946 0.057% (2) Derivatives (other than options) 62,946 0.057% (3) Options and agreements to purchase/sell Total 62,946 62,946 0.057% 0.057% (b) Interests and short positions in relevant securities of the company,other than the class dealt in (Note 2) Class of relevant security: Long Short Number Number (%) (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 2) Class of relevant security: Details 3. DEALINGS (Note 3) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 4) Buy 14,350 1510.36 Sell 5,380 1507.79 (b) Derivatives transactions (other than options) Product name, Long/short (Note 5) Number of securities (Note 6) Price per unit (Note 4) e.g. CFD CFD Short 14,350 1510.36 CFD Long 5,380 1507.79 (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money purchasing, to which the option American,e.g. call option varying etc. relates (Note 6) price European etc. date paid/received per unit (Note 4) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 4) (d) Other dealings (including new securities) (Note 3) Nature of transaction (Note 7) Details Price per unit (if applicable) (Note 4) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingto the voting rights of any relevant securities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form isreferenced. If none, this should be stated. Is a Supplemental Form 38.5(b) attached? (Note 8) YES/NO Date of disclosure 24 April 2008 Contact name Andrew Manchester Telephone number 020 7516 5805Name of offeree/offeror with which connected Expro International group PLCNature of connection (Note 9) JPMorgan Cazenove, an affiliate of Bear Stearns, is acting as the Corporate Broker to Expro International group PLC, Bear Stearns is therefore an associate of Expro International group PLC for the purposes of the City Code on Takeovers and Mergers Notes The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website at http://www.thetakeoverpanel.org.uk/ This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st Aug 20071:43 pmRNSTotal Voting Rights
29th Aug 20072:00 pmRNSNotice of Trading Update
14th Aug 20079:31 amRNSHolding(s) in Company
13th Aug 200711:59 amRNSHolding(s) in Company
1st Aug 20079:44 amRNSBlocklisting Interim Review
31st Jul 20074:21 pmRNSTotal Voting Rights
27th Jul 20072:57 pmRNSDirector/PDMR Shareholding
26th Jul 20077:01 amRNSInterim Management Statement
25th Jul 20078:50 amRNSAdditional Listing
18th Jul 20079:37 amRNSDirector/PDMR Shareholding
18th Jul 20079:36 amRNSDirector/PDMR Shareholding
6th Jul 200712:33 pmRNSDirector/PDMR Shareholding
6th Jul 200712:33 pmRNSDirector/PDMR Shareholding
5th Jul 200712:30 pmRNSCommittee Appointment
5th Jul 200712:30 pmRNSResult of AGM
29th Jun 20074:18 pmRNSTotal Voting Rights
29th Jun 20073:25 pmRNSDirector/PDMR Shareholding
29th Jun 200712:17 pmRNSDirector/PDMR Shareholding
29th Jun 200712:16 pmRNSDirector/PDMR Shareholding
29th Jun 200712:15 pmRNSDirector/PDMR Shareholding
29th Jun 200712:10 pmRNSDirector/PDMR Shareholding
28th Jun 20077:02 amRNSTechnology Conference
27th Jun 20072:35 pmRNSExpro signs LOI for AX-S(TM)
26th Jun 200712:34 pmRNSAnnual Information Update
11th Jun 20073:08 pmRNSHolding(s) in Company
8th Jun 20077:00 amRNSUS Investor Presentation
7th Jun 20076:15 pmRNSAnnual Report and Accounts
1st Jun 200710:54 amRNSBlocklisting Interim Review
31st May 20075:11 pmRNSTotal Voting Rights
31st May 20077:03 amRNSDirectorate Change
31st May 20077:03 amRNSRe Contract
31st May 20077:03 amRNSFinal Results
23rd May 20078:32 amRNSHolding(s) in Company
16th May 200712:19 pmRNSHolding(s) in Company
30th Apr 20074:43 pmRNSTotal Voting Rights
25th Apr 20079:42 amRNSHolding(s) in Company
12th Apr 20077:00 amRNSNotice of Results
10th Apr 20079:20 amRNSHolding(s) in Company
4th Apr 20078:51 amRNSHolding(s) in Company
3rd Apr 20078:58 amRNSHolding(s) in Company
30th Mar 20073:42 pmRNSTotal Voting Rights
27th Mar 20074:08 pmRNSHolding(s) in Company
26th Mar 20077:01 amRNSTrading Statement
19th Mar 20073:05 pmRNSHolding(s) in Company
19th Mar 200712:43 pmRNSHolding(s) in Company
19th Mar 200712:03 pmRNSHolding(s) in Company
12th Mar 20072:38 pmRNSHolding(s) in Company
9th Mar 20073:15 pmRNSHolding(s) in Company
6th Mar 20077:02 amRNSNotice of Trading Update
2nd Mar 20077:30 amRNSDisposal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.